New, solid-phase technologies for HLA antibody screening and identification have emerged that are more sensitive and more specific than previous testing methodologies. Information provided by ...

Chiome Bioscience aims to discover and develop therapeutic antibodies for unmet medical needs using its monoclonal antibody ... phase 1 is complete. CBA-1535, in development for the treatment of ...